SCHEMBL9973676

SCHEMBL9973676

c1cncc(-c2cccc(-c3ccc4c(c3)c3cc(-c5cccc(-c6cccnc6)n5)ccc3n4-c3cccc4ccccc34)n2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.43
CYP2A6 P11509 2/20 0.43
CYP11B1 P15538 3/20 0.42
CYP11B2 P19099 2/20 0.40
CYP17A1 P05093 1/20 0.40
CYP2C9 P11712 2/20 0.39
KDM4E B2RXH2 3/20 0.39
KMT2A Q03164 2/20 0.39
DHODH Q02127 1/20 0.39
CYP1A1 P04798 1/20 0.39
CYP1A2 P05177 1/20 0.39
PRKDC P78527 1/20 0.39
CYP1B1 Q16678 1/20 0.39
MAPT P10636 3/20 0.38
ALDH1A1 P00352 2/20 0.38
HPGD P15428 2/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PDE10A Q9Y233 1/20 0.38
GSK3B P49841 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9973679 0.90 CYP19A1 (0.43) CYP19A1CYP2A6CYP11B1CYP11B2CYP17A1
SCHEMBL2018409 0.87 CYP11B1 (0.44) CYP19A1CYP2A6CYP11B1CYP11B2CYP17A1
SCHEMBL15449954 0.85 CYP11B1 (0.42) CYP19A1CYP2A6CYP11B1CYP11B2CYP17A1
SCHEMBL9973684 0.84 CYP19A1 (0.50) CYP19A1CYP2A6CYP11B1CYP11B2CYP17A1
SCHEMBL9973761 0.83 CYP2A6 (0.41) CYP19A1CYP2A6CYP11B1CYP11B2CYP17A1
SCHEMBL9973710 0.82 CYP19A1 (0.49) CYP19A1CYP2A6CYP11B1CYP11B2CYP17A1
SCHEMBL9973681 0.82 CYP19A1 (0.49) CYP19A1CYP2A6CYP11B1CYP11B2CYP17A1
SCHEMBL18560751 0.80 MAPT (0.45) CYP19A1CYP2A6CYP11B1CYP11B2CYP17A1
SCHEMBL19222809 0.79 CYP19A1 (0.56) CYP19A1CYP2A6CYP11B1CYP11B2CYP17A1
SCHEMBL2020493 0.79 CYP19A1 (0.56) CYP19A1CYP2A6CYP11B1CYP11B2CYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8202633-B2 Electron transport material and organic electroluminescent device using the same JNC CORPORATION (JP) 2012-06-19 US disclosed
US-8202633-B2 Electron transport material and organic electroluminescent device using the same JNC CORPORATION (JP) 2012-06-19 US disclosed
US-20110215310-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME SK MATERIALS JNC CO., LTD. (KR) 2011-09-08 US disclosed
US-20110215310-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME SK MATERIALS JNC CO., LTD. (KR) 2011-09-08 US disclosed
US-7964293-B2 Electron transport material and organic electroluminescent device using the same JNC CORPORATION (JP) 2011-06-21 US disclosed
US-7964293-B2 Electron transport material and organic electroluminescent device using the same JNC CORPORATION (JP) 2011-06-21 US disclosed
US-20090134780-A1 Electron transport material and organic electroluminescent device using the same SK MATERIALS JNC CO., LTD. (KR) 2009-05-28 US disclosed
US-20090134780-A1 Electron transport material and organic electroluminescent device using the same SK MATERIALS JNC CO., LTD. (KR) 2009-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110215310-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME SLC25A11, ELAVL1, SLC26A3 CYP19A1 3499/4885CYP2A6 4405/4885CYP11B1 1482/4885
US-20090134780-A1 Electron transport material and organic electroluminescent device using the same SLC25A11, ELAVL1, SLC26A3 CYP19A1 3499/4885CYP2A6 4405/4885CYP11B1 1482/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.